Natural Health Trends Corp.

NHTC

Consumer Cyclical Internet Retail

Natural Health Trends Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.8 million, down 7.42% from fiscal 2024.

Revenue
−20.2%
EPS
+32.5%
Free cash flow
−1,670.0%

Quarter to September 2026, against a year earlier

0.75 0.02 +2.74%
Market cap
$6.2M
P/E
n/m
Fwd P/E
75.1×
Dividend yield
53.3%
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
17.0×
Dividend safety
20/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
6 6 4 3 7 6 3 5 4 3
P/E ratio
5.03 7.54 6.75 0.00 59.86 71.84 103.23 131.11 86.36 0.00
P/S ratio
0.97 0.90 1.09 0.75 0.85 1.24 0.81 1.54 1.23 0.89
Altman Z-Score
7.01 4.83 4.97 2.29 2.43 2.65 1.97 2.43 2.10 1.61
P/FCF ratio
5.32 6.77 7.09 0.00 31.62 94.15 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
8.81 8.61 8.19 6.40 6.99 6.30 5.76 4.79 3.40 1.73
P/Operating CF
16.48 15.81 46.99 531.69 15.50 47.35 42.64 (977.86) 602.02 (37.04)
Dividend Safety Score
— — — — — — — — — 20
P/B ratio
3.38 1.97 2.33 0.78 0.78 1.25 0.80 1.62 1.61 1.52
Price to Tangible BV
3.45 2.00 2.37 0.80 0.80 1.29 0.83 1.69 1.70 1.64
EV/Sales
0.53 0.22 0.40 (0.48) (0.64) (0.16) (0.60) 0.26 0.21 0.17
EV/EBITDA
2.36 0.98 2.24 7.71 0.00 0.00 449.59 0.00 0.00 0.00
EV/Operating CF
2.87 1.61 2.57 2.01 (20.92) (9.22) 6.12 (2.64) (2.68) (1.11)
EV/FCF
2.92 1.63 2.59 1.99 (23.55) (11.84) 5.94 (2.61) (2.64) (1.10)
Quick Ratio
2.20 3.23 3.08 3.65 4.29 3.40 3.41 2.81 2.11 2.11
Current Ratio
2.47 3.61 3.49 4.12 4.64 3.79 3.79 3.21 2.45 2.50
Net Debt/EBITDA
(1.95) (3.10) (3.88) 19.71 (85.60) (44.84) 1,055.56 37.28 37.62 16.99
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
2.11 1.28 1.21 0.56 0.55 0.59 0.54 0.58 0.69 0.85
Operating CF/Net income
0.97 1.13 0.96 3.32 2.24 0.94 (15.50) (7.53) (5.89) 6.80
Capex/Depreciation
(2.30) (0.52) (0.50) (0.09) (0.51) (0.75) (0.70) (0.28) (0.44) (0.62)
ROE
79.12% 27.25% 34.39% (6.80%) 1.18% 1.71% 0.57% 1.24% 1.54% (3.13%)
ROA
40.47% 15.33% 19.55% (4.06%) 0.75% 1.06% 0.35% 0.75% 0.92% (1.88%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
64.44% 21.34% 28.73% (6.78%) 1.07% 1.57% 0.54% 1.28% 1.88% (4.27%)
Average Days of Receivables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
15.03% 16.31% 16.31% 35.07% 29.33% 29.74% 32.56% 36.44% 36.11% 37.11%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.04% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.37% 0.34% 0.33%
Graham Net Nets
0.27 0.46 0.39 1.11 1.16 0.73 1.12 0.54 0.54 0.54
Graham Number
28.14 19.51 22.14 0.00 3.45 3.38 1.84 1.92 1.86 0.00
Earnings Yield
19.88% 13.27% 14.82% (9.67%) 1.67% 1.39% 0.97% 0.76% 1.16% (2.55%)
Free Cash Flow Yield
18.78% 14.78% 14.11% (32.19%) 3.16% 1.06% (12.49%) (6.41%) (6.46%) (17.07%)
Revenue per Share
25.28 17.56 16.98 7.14 5.84 5.45 4.32 3.84 3.75 3.46
Operating CF per Share
4.67 2.36 2.63 (1.71) 0.18 0.09 (0.43) (0.37) (0.29) (0.52)
Capex per Share
(0.08) (0.02) (0.02) (0.02) (0.02) (0.02) (0.01) 0.00 0.00 (0.01)
Free Cash Flow per Share
4.59 2.34 2.61 (1.73) 0.16 0.07 (0.44) (0.38) (0.30) (0.53)
Cash per Share
11.06 12.03 11.74 8.83 8.69 7.61 6.13 4.91 3.83 2.51
Shareholders Equity per Share
7.24 8.05 7.95 6.91 6.37 5.40 4.41 3.64 2.87 2.04
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
7.24 8.05 7.95 6.91 6.37 5.40 4.41 3.64 2.87 2.04
Free Cash Flow
52.27 26.33 29.50 (18.83) 1.67 0.79 (4.99) (4.32) (3.42) (6.06)
Working Capital
84.09 109.32 107.10 82.07 78.24 68.81 57.11 44.25 30.18 20.51
Capital Expenditures
(0.90) (0.28) (0.21) (0.19) (0.21) (0.22) (0.14) (0.05) (0.06) (0.07)
Net Current Asset Value
75.63 82.31 82.13 64.94 61.50 54.60 44.89 36.74 28.50 19.20
EV/EBIT
2.38 0.99 2.26 5.35 0.00 0.00 109.90 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
4.34 4.14 6.20 0.00 79.13 47.41 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.28 0.47 0.45 2.93 0.76 0.65 0.52 0.62 0.69 0.71
Cash ROIC
25.09% 11.65% 13.26% (11.00%) 1.05% 0.55% (4.17%) (4.42%) (4.46%) (11.60%)
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
21.93 19.84 23.28 17.40 26.97 22.39 16.12 12.42 11.86 14.51
Inventory Turnover
5.06 3.93 3.83 2.17 3.34 3.32 2.59 2.53 2.96 3.96
Average Days of Payables
14.26 16.54 15.12 12.35 12.46 18.51 23.35 32.34 29.22 19.25
Days of Inventory on Hand
74.84 79.32 112.79 116.27 81.19 127.84 130.45 140.22 106.84 71.00
Average Payables
2.50 1.95 1.69 1.16 0.63 0.67 0.79 0.90 0.94 0.73
Average Inventory
10.86 9.83 10.28 9.28 5.09 4.52 4.89 4.41 3.78 2.66
Average Assets
136.10 153.80 158.74 138.21 112.22 102.15 90.59 75.95 62.23 46.89
Average Common Equity
69.62 86.53 90.24 82.46 71.38 63.59 54.82 45.88 37.24 28.15

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026